Table 2 Patient characteristics

From: Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Characteristic

 

Sex

 Male

17

 Female

7

Mean (range) age (years)

66 (38–85)

Chemotherapy

 Carboplatin+pemetrexed

23

 Cisplatin+pemetrexed

1

Tumor histology

 Adenocarcinoma

21

 Squamous cell

1

 Other

2

Disease stage

 IIIB

7

 IV

17

Tumor response

 CR+PR

7

 SD

13

 PD

4

  1. Abbreviations: CR=complete response; PD=progressive disease; PR=partial response; SD=stable disease.